0
10. 6. 2020.
Canadian Treat-and-Extend Trial with Ranibizumab in nAMD Patients: CANTREAT 36 Month Anatomic Outcomes
Canadian Treat-and-Extend Trial with Ranibizumab in nAMD Patients: CANTREAT 36 Month Anatomic Outcomes
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više